Adapting the therapy by associating an adequate ultra–filtration and the administration ofan anti–hypertensive medication based on ACE inhibitors, with a prolonged half time, associatedor not with other categories of anti–hypertensive drugs, is the key in managing this type of HT. Here, ACE is linked to hematocrit.